Home/Filings/8-K/0001193125-26-021189
8-K//Current report

Bain Capital Specialty Finance, Inc. 8-K

Accession 0001193125-26-021189

$BCSFCIK 0001655050operating

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:48 PM ET

Size

372.8 KB

Accession

0001193125-26-021189

Research Summary

AI-generated summary of this filing

Updated

Bain Capital Specialty Finance Announces $350M Note Offering

What Happened
Bain Capital Specialty Finance, Inc. announced on January 22, 2026 that it entered into an underwriting agreement to issue and sell $350 million aggregate principal amount of its 5.950% Notes due 2031. The agreement names Wells Fargo Securities, J.P. Morgan Securities, and SMBC Nikko Securities America as the representatives of the underwriters and contains customary representations, warranties, covenants and indemnification provisions.

Key Details

  • Offering size: $350,000,000 aggregate principal amount of 5.950% Notes due 2031.
  • Agreement date: January 22, 2026; offering made under the company’s effective Form N-2 shelf registration (Reg. No. 333-288343) and prospectus supplements dated January 22, 2026.
  • Underwriters’ reps: Wells Fargo Securities, J.P. Morgan Securities, and SMBC Nikko Securities America.
  • The underwriting agreement (filed as Exhibit 1.1 to the 8-K) includes customary indemnification and contribution terms.

Why It Matters
This is a debt capital raise: issuing $350M of fixed‑rate, long‑term notes will increase BCSF’s interest-bearing liabilities and interest expense, and provide cash to support the company’s lending and investment activities or other corporate needs. Investors should note the size, fixed coupon (5.950%) and maturity (2031) when assessing BCSF’s future leverage, interest coverage and potential impact on earnings. The transaction follows the company’s existing shelf registration and appears structured with standard underwriting protections.